SEGMENT INFORMATION

12 Months Ended

Mar. 29, 2014

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage a global business which designs, manufactures and markets blood management solutions.  Our solutions are marketed through operating units organized based primarily on geography: North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific and Japan. Prior to fiscal 2014 we determined we operated a single operating segment, blood management solutions, based on our CODM primarily using consolidated results to make operating and strategic decisions. During fiscal 2014 our CODM utilized financial results by operating units organized primarily on geography due to changes in the composition in the executive staff reporting to the CODM. Based on these changes we determined the five operating units noted above represent operating segments as defined under ASC 280 - Segment Reporting.

ASC 280 - Segment Reporting permits aggregation of segments which are economically similar as well as similar in all of the following areas: (i) the nature of the products and services, (ii) the nature of the production processes, (iii) the type or class of customer for their products and services, (iv) the methods used to distribute their products or provide their services, and (v) the nature of the regulatory environment. We determined each operating segment is similar based on the criteria of ASC 280 and accordingly aggregate our five operating segments into one reportable segment. This conclusion is consistent with how our chief operating decision-maker views the business. Our chief operating decision maker primarily uses consolidated results to make operating and strategic decisions.

Enterprise Wide Disclosures About Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver^® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery).

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

(In thousands)	March 29, 2014		March 30, 2013		March 31, 2012
Disposable revenues
Plasma disposables	$	291,895	$	268,900	$	258,061
Blood center disposables
Platelet	156,643		169,602		167,946
Red cell	42,378		49,733		48,034
Whole blood	190,698		138,436		—
	389,719		357,771		215,980
Hospital disposables
Surgical	66,876		73,508		66,619
OrthoPAT	25,042		30,230		31,186
Diagnostics	33,302		27,356		23,087
	125,220		131,094		120,892
Disposables revenue	806,834		757,765		594,933
Software solutions	70,441		69,952		70,557
Equipment & other	61,234		64,273		62,354
Total revenues	$	938,509	$	891,990	$	727,844

Enterprise Wide Disclosures About Product and Services

Year Ended (in thousands)

March 29, 2014	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	500,719	$	9,557	$	510,276	$	108,679	$	94,762	$	224,792	$	938,509
Total Assets	$	810,409	$	225,998	$	1,036,407	$	53,207	$	53,055	$	371,509	$	1,514,178
Long-Lived Assets	$	519,396	$	211,624	$	731,020	$	11,522	$	17,269	$	131,391	$	891,202

March 30, 2013	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	454,874	$	6,851	$	461,725	$	120,726	$	84,860	$	224,679	$	891,990
Total Assets	$	830,754	$	225,849	$	1,056,603	$	44,189	$	41,037	$	320,088	$	1,461,917
Long-Lived Assets	$	503,606	$	209,439	$	713,045	$	12,977	$	8,076	$	117,717	$	851,815

March 31, 2012	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	352,160	$	512	$	352,672	$	124,381	$	67,223	$	183,568	$	727,844
Total Assets	$	634,171	$	15,365	$	649,536	$	50,509	$	27,353	$	183,737	$	911,135
Long-Lived Assets	$	305,370	$	12,796	$	318,166	$	13,128	$	3,961	$	38,009	$	373,264

The Long-Lived Assets reported above include Goodwill, Intangibles and Net Property, Plant and Equipment.